Security key
80880W205
Scilex Holding Co - Common Stock, $0.0001 par value per share (SCLX)
CUSIP: 80880W205
Q4 2024 13F Holders as of 31 Dec 2024
- Security type / class
- Equity / Common Stock, $0.0001 par value per share
- Total 13F shares
- 19
- Total 13F value
- $8
- Share change
- 0
- SEC-reported price per share
- $0.42
- Number of holders
- 1
- Shares outstanding
- 263,415,596
Holder snapshot
3 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2024
Institutions
1
Top holders
1
SCLX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2025
Scilex Holding Co SEC filings
Scilex Holding Co company facts
Scilex Holding Co 13D/G history
Broader feeds
Reporting periods
Holder history for CUSIP 80880W205
Recent filing periods:
Ownership snapshot
Top reported holders of SCLX - Scilex Holding Co - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Sorrento Therapeutics, Inc.
Disclosed value leader
STATE STREET CORP
Comparable rows
0/15
Latest evidence
30 Sep 2024
3/4/5
13F
Highest disclosed value: $6,919,993
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
STATE STREET CORP has the largest disclosed position value at $6.92M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens STATE STREET CORP's linked filing trail.
Disclosed position value
Top 5
Sorrento Therapeutics, Inc.
$1.69M
STATE STREET CORP
$6.92M
BlackRock, Inc.
$6.2M
VANGUARD GROUP INC
$5.59M
ARMISTICE CAPITAL, LLC
$3.25M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Sorrento Therapeutics, Inc. |
3/4/5
10%+ Owner
|
—
denominator unverified
|
$1,687,145
1,917,210 shares
|
— | 21 Sep 2023 |
| Vickers Venture Fund VI Pte Ltd |
3/4/5
Other*, 10%+ Owner
|
—
denominator unverified
|
—
1,000,000 shares
|
— | 10 Nov 2022 |
| STATE STREET CORP |
13F
Company
|
—
denominator unverified
|
$6,919,993
7,484,310 shares
|
— | 30 Sep 2024 |
| BlackRock, Inc. |
13F
Company
|
—
denominator unverified
|
$6,201,942
6,707,701 shares
|
— | 30 Sep 2024 |
| VANGUARD GROUP INC |
13F
Company
|
—
denominator unverified
|
$5,585,346
6,038,211 shares
|
— | 30 Sep 2024 |
| ARMISTICE CAPITAL, LLC |
13F
Company
|
—
denominator unverified
|
$3,245,346
3,510,000 shares
|
— | 30 Sep 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
1
Shares
19
Rows available
1
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2024 vs Q2 2026 Across Filers
Q2 2026 holders
70
Q4 2024 holders
1
Holder diff
-69
| Investor | Q2 2026 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q2 2026 value | Q4 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend